Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
May 12th, 2022
The standard membrane feeding assay (SMFA) is regarded as the gold standard for the assessment and identification of potential antimalarial compounds. This artificial feeding system is used to infect mosquitoes to further evaluate the effects of such compounds on the intensity and prevalence of the Plasmodium falciparum parasite.
The protocol allows us to detect the effect of treatment on the malaria susceptibility of African malaria vectors. For example, compounds aimed at blocking transmission from the human to the mosquito. This technique allows researchers to evaluate a large number of compounds under laboratory conditions, even before toxicity GATEs are available.
Midgut dissections can be challenging at first but it just takes some practice. Also, to be able to identify oocysts is not always easy. First, using a mouth aspirator, place 25 unfed female Anopheles gambiae mosquitoes into a 350 milliliter feeding cup.
Label the cups clearly to distinguish between control and treatment groups. Choose the number of cups per treatment according to the number of technical replicates included. Connect the glass feeder system to a water bath and maintain the temperature at 37 degrees Celsius.
Then, prepare the cow intestine or synthetic membrane by rinsing it in tap water and cutting it into pieces that are fitted for each feeder. Cover the bottom part of each feeder and fasten the membrane with an elastic band. For using the feeding cups as infection cups, first, keep the membrane on top of the nets of the cups.
Then place the infection cups underneath the feeders. Now, add one milliliter of gametocyte-infected blood to the feeders of the control cups, and gametocyte-infected blood with a test compound to the feeders of the treatment cups. Then leave the mosquitoes to feed for about 40 minutes.
After feeding, remove the feeders from the cups, rinse the feeders, and treat the excess blood with hypochlorite. Then, knock all the mosquitoes down on the ice for one to two minutes, and select the mosquitoes that have taken a blood meal by looking for swollen and red abdomens. Replace the sugar water that is given on alternate days to each infection cup with a 10%sugar water pad, and incubate the infection cups in a biosafety chamber for eight to 10 days.
Eight to 10 days after feeding, knock the infected mosquitoes down by placing them on ice. Then, transfer them to labeled tubes with 70%ethanol, keeping control in each treatment group in separate tubes. Keeping the control and test groups separate, transfer the mosquitoes to labeled Petri dishes lined with filter paper.
Add a drop of PBS on an appropriately-marked glass slide, and transfer a mosquito from the filter paper to the drop. Pin the thorax of the mosquito with dissecting needle. Then, remove the midgut by pulling the seventh abdominal segment with forceps, and transfer it to a droplet of 0.1%mercurochrome on a new microscope slide.
Leave the gut to stain for eight to 10 minutes. Then place a cover slip on the stained gut, and view it under bright field illumination at 20 to 40 times magnification. Record the number of oocysts per midgut for the control and each treatment group.
In this study, the compound MMV1581558 was found to significantly restrict the number of Plasmodium falciparum oocysts in the midgut of female Anopheles gambiae mosquitoes in comparison to the control. In the control group, the average prevalence of oocysts in the midgut was 89%with an average intensity of 9.5 oocysts per midgut. But in the MMV1581558 treated group, the average oocysts prevalence was 36%with an average intensity of only 1.5 oocysts per midgut.
Thus, MMV1581558 treatment resulted in 58%transmission blocking activity and 82%transmission reducing activity in all three biological replicates. It is critical to ensure that mosquitoes feed on a healthy gametocyte culture. If these are immature gametocytes, or not stage five gametocytes, the probability of getting an infection in the mosquito is limited or impossible.
The assay uses a visual morphological identification method, however, molecular quantification assays can be used. This is, however, costlier and might limit their use in resource-constrained laboratories. Having the ability to do this technique opens up new avenues to evaluate the change of malaria prevalence and intensity between almost anything in mosquito.
For example, comparing species vectorial capacity.
View the full transcript and gain access to thousands of scientific videos
Overview
The standard membrane feeding assay (SMFA) is a crucial method for assessing potential antimalarial compounds. This technique enables researchers to infect mosquitoes and evaluate the effects of these compounds on the Plasmodium falciparum parasite.
Key Study Components
Area of Science
- Parasitology
- Entomology
- Pharmacology
Background
- The SMFA is considered the gold standard for antimalarial compound assessment.
- This method allows for the study of malaria transmission dynamics.
- It facilitates the evaluation of compounds before toxicity assessments.
- Midgut dissections are essential for analyzing the effects on malaria vectors.
Purpose of Study
- To detect the impact of treatments on malaria susceptibility in mosquito vectors.
- To evaluate compounds that block transmission from humans to mosquitoes.
- To enhance understanding of malaria transmission mechanisms.
Methods Used
- Use of a mouth aspirator to collect mosquitoes.
- Placement of unfed female Anopheles gambiae into feeding cups.
- Midgut dissections to identify oocysts.
- Assessment of compound effects under controlled laboratory conditions.
Main Results
- Successful infection of mosquitoes with Plasmodium falciparum.
- Evaluation of multiple compounds for their antimalarial properties.
- Identification of oocysts in mosquito midguts.
- Insights into the transmission blocking potential of tested compounds.
Conclusions
- The SMFA is an effective tool for antimalarial research.
- It allows for the rapid screening of potential therapeutic compounds.
- Further studies are needed to optimize midgut dissection techniques.
Frequently Asked Questions
Executive Industry Relevance
The standard membrane feeding assay (SMFA) is a pivotal tool for evaluating the transmission-blocking efficacy of antimalarial compounds in vector biology. By enabling quantitative assessment of Plasmodium falciparum infection in Anopheles mosquitoes, SMFA supports early-stage target validation and mechanistic de-risking in anti-infective discovery pipelines. This assay underpins portfolio decisions by providing predictive confidence in compound selection before advancing to more resource-intensive studies.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of compound effects on parasite transmission within the vector.
- Supports functional validation of transmission-blocking targets in a biologically relevant system.
- Facilitates mechanistic de-risking by quantifying oocyst prevalence and intensity post-treatment.
- Provides data to triage candidate molecules based on transmission-blocking potential.
Screening & Assay Development
- Establishes a standardized, reproducible workflow for evaluating compound efficacy in vector infection models.
- Generates quantitative outputs (oocyst counts) suitable for comparative analysis across test and control groups.
- Supports scalability for screening multiple compounds under controlled laboratory conditions.
- Enables reliable assessment of compound impact prior to toxicity or in vivo studies.
Translational & Preclinical Research
- Aligns with disease-relevant transmission models, bridging discovery and translational research.
- Provides continuity from in vitro compound screening to in vivo vector infection outcomes.
- Informs risk-adjusted advancement of candidates with demonstrated transmission-blocking activity.
- Supports the identification of translational biomarkers such as oocyst prevalence and intensity.
Pipeline & Workflow Integration
The SMFA is positioned at the interface of early discovery and lead identification, enabling hypothesis-driven evaluation of antimalarial compounds in a vector context before preclinical development.
- Discovery Biology: Facilitates hypothesis testing on compound-mediated transmission blocking in Anopheles vectors.
- Screening: Delivers reproducible, quantitative infection readouts for robust compound comparison.
- Analytics: Provides statistical outputs (prevalence, intensity) to inform go/no-go decisions.
- Translational Research: Connects laboratory findings to disease-relevant transmission endpoints.
- Enterprise Reuse: Offers a reusable platform for evaluating diverse compounds and interventions targeting malaria transmission.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in transmission-blocking efficacy and reduces mechanistic ambiguity.
- Operational Value: Standardizes infection assessment and supports reproducibility across technical replicates.
- Strategic Value: Enables informed go/no-go decisions and optimizes resource allocation in anti-infective portfolios.
- Portfolio Impact: Supports risk-adjusted prioritization of candidates with validated vector-stage activity.
Implementation Considerations
- Requires technical expertise in mosquito handling and midgut dissection.
- Needs access to controlled laboratory infrastructure and microscopy for oocyst quantification.
- Demands rigorous cross-team standardization of infection and staining protocols.
- Adaptation may be needed for different mosquito or Plasmodium species.
- Visual identification is cost-effective but may limit throughput compared to molecular quantification methods.
